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Abstract: MicroRNAs (miRNAs) have recently been shown to play fundamental roles in diverse cellular processes 
and linked to variety of cancers. Dicer and Drosha are two major enzymes in the miRNA maturation process. DGCR8 
is the assistant of Drosha in the microprocessor complex. In this study, we evaluated the mRNA expression profiles 
of major miRNA processing machinery Drosha, Dicer, and DGCR8 in human gastrointestinal (AGS, KYSE30 and 
HepG2) cancer cell lines. Materials and Methods: The cells were cultured and harvested, and total cellular RNA was 
isolated from cells. Then, first-strand cDNA was synthesized from the RNA of cells. Afterward, Quantitative analysis 
was performed by real-time RT-PCR using the PowerSYBR Green PCR Master Mix. Results: Expression levels of Dro-
sha in AGS and HepG2 cells were higher than the controls, whereas, Drosha’s expression level in KYSE-30 cell line 
was lower. The Dicer expression levels in AGS and HepG2 cells were higher, while, its expression level in KYSE-30 
cell was lower. The DGCR8 expression levels in all three cell lines were significantly higher than the control samples. 
Conclusion: Expression levels of the two most important enzymes of the miRNA machinery, Drosha and Dicer, and 
microprocessor complex component, DGCR8 were noticeably dysregulated when compared to healthy controls.
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Introduction
MicroRNAs (miRNA) are 17 to 24 nucleotide (nt) 
RNA molecules that are considered as a group 
of non-protein-coding RNAs; miRNAs are capa-
ble of post-transcriptional gene regulation by 
binding to target mRNAs [1]. The miRNA base-
pairs with target mRNA to direct gene silencing 
through mRNA cleavage or translation repres-
sion based on the level of complementarily 
between the miRNA and the mRNA target [2]. 
miRNAs have recently been shown to play fun-
damental roles in diverse developmental and 
cellular processes and linked to variety of can-
cers [3].
miRNA maturation begins in the nucleus, where 
the primary miRNA (pri-miRNA) transcript is 
transcribed by RNA polymerase II [4]. The RNA 
III endonuclease Drosha inside the nucleus, 
beside with DiGeorge syndrome critical region 
gene 8 (DGCR8 or Pasha) construct the micro-
processor complex. This complex cuts the pri-
miRNA transcript within the nucleus into several 
precursor miRNAs (pre-miRNAs) [5]. Drosha is 
the catalytic subunit of the pri-miRNA process-
ing microprocessor complex, while DGCR8 sta-
bilizes Drosha and recognizes the RNA sub-
strate [6, 7]. The 70-90 nt long pre-miRNAs are 
then transported to the cytoplasm for further 
processing, where Dicer, another RNase III 
enzyme cleaves it to produce mature miRNA [8]
Although several studies have revealed dysreg-
ulation of microRNA (miRNA) expression pro-
files in various cancers, there has been little 
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research on the miRNA machinery itself. In this 
study, we evaluated the mRNA expression pro-
files of major miRNA processing machinery 
Drosha and Dicer, and DGCR8 in human gastro-




The human cancer cell lines including, human 
gastric carcinoma (AGS), human esophageal 
squamous cell carcinoma (KYSE-30), and 
human hepatocellular carcinoma (HepG2) were 
purchased from Pasteur Institute of Iran Cell 
Bank (Tehran, Iran). All reagents and medium 
were prepared just before use. Normal cells 
were obtained from healthy people.
Cell culture
The cells were cultured in RPMI-1640 (Cat. No: 
51800–035, GIBCO, UK) medium supplement-
ed with 10% fetal bovine serum (FBS; Cat. No: 
10270–106, GIBCO, UK), penicillin 100 unit/ml 
and streptomycin 100 μg/ml. The cells were 
incubated at 37°C in a water saturated atmo-
sphere of 5% CO2 and 95% air until confluence. 
One week later, the cells were removed with a 
solution containing 0.25 (w/v) trypsin and 0.02 
(w/v) ethylenediaminetetraacetic acid.
RNA isolation
Total cellular RNA was isolated from cells using 
Trizol reagent (Cat. No: 15596-026, Invitrogen, 
CA, USA), following this procedure; cultured 
cells were harvested and centrifuged (1000 
rpm, 10 min) for removing supernatant media; 
afterward 0.8ml of Trizol reagent were added 
per 5x106 cell, after pipetting, 0.2ml of chloro-
form were added and tubes were shaken vigor-
ously, after that samples were centrifuged at 
12000g for 15min at 4°C, then upper aqueous 
phase was transferred to a new tube by angling 
the tube at 45° and pipetting the solution out, 
subsequently 0.5ml of isopropanol were added 
and incubated at room temperature for 10min, 
next samples were centrifuged at 12000g for 
10min at 4°C, after that supernatants were 
removed and pellet of the tubes were washed 
and vortexed with 1ml of 75% ethanol and were 
centrifuged at 7500g for 5min at 4°C, finally 
supernatants were discarded and RNA pellets 
were air dried for 10min; and were re-suspend-
ed in 40µl of RNAase free water. Prepared 
RNAs were stored at -80°C refrigerator until 
downstream application.
Reverse transcription and cDNA synthesis
First-strand cDNA was synthesized from the 
RNA of cells by RevertAid First Strand cDNA 
Synthesis Kit, Fermentas (Cat No: #K1621, 
Maryland, USA) according to the manufactur-
er’s protocol. Briefly, 4μl of isolated RNA from 
cells were mixed with 1μl of random hexamer 
primer and 7μl RNAase-free water and incubat-
ed at 65°C for 5min. then micro-tubes were 
chilled on ice, afterward, mixture of (reaction 
buffer 4μl + RNAase inhibitor 1μl + dNTP mix 
2μl + reverse transcriptase 1μl) was added on 
each sample. Immediately samples were incu-
bated at 25°C for 5min followed by 42°C for 
60min; the reaction was terminated by heating 
at 70°C for 5min. Reverse transcription was 
performed in the final volume of 20μL.
Real-time quantitative RT-PCR
Primers were used from previous studies [9, 
10] that Sand, et al, evaluated Drosha, Dicer, 
DGCR8 and RISC components in their studies. 
Primers (Drosha, Dicer, DGCR8 and the RPL38 
as a housekeeping gene) were designed using 
Primer Express 3.0 (PE Applied Biosystems, 
Foster City, CA, USA). See Supplementary Table 
1 for the details of primers used in quantitative 
real-time PCR. For accuracy and specificity all 
primers were blasted in NCBI website: http://
www.ncbi.nlm.nih.gov/tools/primer-blast/. 
Primers were produced by the custom oligonu-
cleotide synthesis service, Metabion 
(Martinsried, Germany).
Quantitative analysis was performed by real-
time RT-PCR using the PowerSYBR Green PCR 
Master Mix (Cat. No: 4309155, Applied 
Biosystems, Foster City, CA, USA) and StepOne 
Real-Time PCR System (Applied Biosystems 
7500, Foster City, CA, USA). Each reaction mix-
ture contained a total volume of 25μl (master 
mix 12.5μl, cDNA 3μl, primer 3μl, and H2O 
6.5μl).
The quantitative RT-PCR conditions were: 50°C 
for 2 minutes, 95°C for 10 minutes, then 60 
cycles of 95°C for 30 seconds, and 60°C 30 
seconds and 72°C for 30 seconds. 
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Figure 1. Expression of Drosha mRNA in cell lines 
AGS, HepG2 and KYSE30 was evaluated by quantita-
tive RT-PCR. Values presented in the log scale. (HS: 
healthy subjects).
Relative amounts of target mRNA in test sam-
ple was calculated and normalized to the cor-
responding RPL38 mRNA transcript level as a 
housekeeping gene. The comparative Ct meth-
od was used to evaluate expression as previ-
ously described by Livak and Schmittgen [11].
Statistical analysis
Data analysis was performed using a graph and 
data analysis software package (SigmaPlot 
12.0, Systat Software, Inc.). Data were ana-
lyzed by paired t-tests to compare cell lines with 
healthy controls.
Results
Expression levels of Drosha in AGS and HepG2 
cells were higher than the controls (P = 0.011 
and P = <0.001 respectively). On the contrary, 
Drosha’s expression levels in KYSE-30 cell line 
were lower in comparison to the control (Figure 
1, P = 0.038).
The Dicer expression levels in AGS and HepG2 
cells were higher than the controls (P = 0.013 
and P = 0.009 respectively). In contrast, Dicer 
expression levels in KYSE-30 cell line were 
lower in comparison to the control (Figure 2, P 
= <0.001).
The DGCR8 expression levels in all three cell 
lines were significantly higher than the control 
samples (Figure 3). There was a statistically 
significant difference between AGS and HepG2 
and healthy subjects (P = <0.001), and also 
between KYSE30 and normal controls (P= 
0.013).
Discussion
Changes in the microRNA machinery compo-
nents play crucial roles in the carcinogenesis of 
a variety of tumors [12]. These alterations are 
thought to elucidate abnormal miRNA profiles 
in various cancers. Both down and up-regula-
Figure 2. Expression of Dicer mRNA in cell lines AGS, 
HepG2 and KYSE30 was evaluated by quantita-
tive RT-PCR. Values presented in the log scale. (HS: 
healthy subjects).
Figure 3. Expression of DGCR8 mRNA in cell lines 
AGS, HepG2 and KYSE30 was evaluated by quantita-
tive RT-PCR. Values presented in the log scale. (HS: 
healthy subjects).
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Table 1. Primers used in quantitative PCR, the amplicon sizes and the melting temperature (Tm) of 
each reaction
Target Sequence Amplicon Size (bp) Tm (°C)
Dicer F  5′-TTAACCTTTTGGTGTTTGATGAGTGT-3′ 94 58.5
Dicer R 5′-GGACATGATGGACAATTTTCACA-3′ 57.1
Drosha F 5′-CATGTCACAGAATGTCGTTCCA-3′ 115 58.4
Drosha R 5′- GGGTGAAGCAGCCTCAGATTT-3′ 59.8
DGCR8 F 5′-GCAAGATGCACCCACAAAGA-3′ 93 57.3
DGCR8 R 5′-TTGAGGACACGCTGCATGTAC-3′ 59.8
RPL38 F 5′-TCACTGACAAAGAGAAGGCAGAGA-3′ 88 61
RPL38 R 5′-TCAGTGTGTCTGGTTCATTTCAGTT-3′ 59.7
F: forward primer, R: reverse primer, bp: base pairs, RPL38: ribosomal protein (housekeeping gene).
tion of miRNAs have been reported, however, it 
is not clear whether the observed up- or down-
regulation of miRNA expression simply reflects 
malignant weakening of the tumor or directly 
causes tumor triggering and progression [9]. 
Hence, there are studies that have been proven 
both down and up-regulation of these machin-
ery components in a variety of cancers [10, 
13-17]. Since miRNAs control both oncogene-
sis and tumor suppressors, it remains doubtful 
whether miRNAs may control carcinogenesis. 
To analyze expression levels of important 
miRNA machinery components, we evaluated 
expression levels of two essential enzymes in 
the miRNA maturation process, Dicer and 
Drosha. And also DGCR8 which is a double-
stranded RNA binding protein (dsRBP) and 
determines the cleavage sites on the pri-miR-
NA. Furthermore, there are also other factors 
that are necessary for appropriate pri-miRNA 
processing and are the subject of current 
research [18]. They include RNA-induced silenc-
ing complex (RISC) components including, argo-
naute-1 (AGO1), argonaute-2 (AGO2), as well as 
double-stranded RNA-binding proteins PACT, 
TARBP1, and TARBP2 [19]. Nevertheless, in 
this pilot study, we investigated the expression 
of Dicer, Drosha and DGCR8, while the other 
factors could be the subject of further studies.
It has been established that Drosha expression 
were correlated with poor prognostic factors in 
prostate cancer and esophageal carcinoma, 
besides, reduction of Drosha expression by 
means of siRNA has been reported to reduce 
cellular proliferation in esophageal cancer cell 
lines [20]. There are several probable explana-
tions for the divergent expression patterns of 
Drosha in various tumors and how they corre-
late with other pathological parameters. Here, 
we found expression levels of Drosha in AGS 
and HepG2 cells were up-regulated (P = 0.011 
and P = <0.001); on the other hand, it was 
down-regulated in KYSE-30 cell line (P = 0.038). 
Regardless of growing evidence that Dicer 
mRNA levels differ in tumors, the regulation of 
this gene is indefinite. Dicer gene mutations 
have been found in humans, and alterations of 
the Dicer gene were detected in some pre-can-
cerous and invasive lung adenocarcinomas 
[21]. Additionally, there are other studies that 
suggest miRNA processing may be hindered in 
tumors with low Dicer and low Drosha expres-
sion, which could lead to a poor clinical out-
come [13, 22]. In our study we found that the 
expression of Dicer in AGS and HepG2 cells 
were higher than the controls (P = 0.013 and P 
= 0.009), on the other side, we have seen it was 
down-regulated in KYSE-30 cell line (P = 
<0.001).
DGCR8 is an RNA-binding protein that assists 
Drosha in the processing of miRNAs. Our exper-
iment showed that DGCR8 expression up-regu-
lated in AGS and HepG2 cells (P = <0.001), and 
also in KYSE30 cell line (P= 0.013).
To sum up all the facts, expression levels of the 
two most important enzymes of the miRNA 
machinery, Drosha and Dicer, and microproces-
sor complex component, DGCR8 were clearly 
dysregulated when compared to healthy con-
trols. Our results are consistent with other find-
ings and propose that miRNAs are involved in 
the carcinogenesis, and emphasize the impor-
tance of miRNA expression profiles to further 
investigate the role of miRNA dysregulation in 
human cancers.
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However, this cannot be assessed based on 
our data alone. Hence, this was an in vitro 
study; it would be much more informative to 
design other experiments on animal tumor 
models and especially human tumors.
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